Comparative Outcomes of iVAC2L and IABP Support in High-Risk PCI: Six-Month Survival and Complication Analysis
Conclusion: Patients with iVAC2L MCS had higher 6-month survival compared to IABP in high-risk PCI, albeit without statistically significant differences. Both devices provided effective hemodynamic support during the intervention with no periprocedural mortality. Vascular complications were numerica...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of Interventional Cardiology |
| Online Access: | http://dx.doi.org/10.1155/joic/9755662 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Conclusion: Patients with iVAC2L MCS had higher 6-month survival compared to IABP in high-risk PCI, albeit without statistically significant differences. Both devices provided effective hemodynamic support during the intervention with no periprocedural mortality. Vascular complications were numerically more frequent with iVAC2L, highlighting the need for skilled vascular access management. Larger prospective studies are needed to confirm these findings and guide optimal MCS device selection for high-risk PCI. |
|---|---|
| ISSN: | 1540-8183 |